title: Side effects related to cancer treatment: CASE 1. Hepatitis following treatment with gefitinib.
authors.affiliation: Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
authors.forename: Cheryl
authors.initials: C
authors.lastname: Ho
authors.forename: Jennifer
authors.initials: J
authors.lastname: Davis
authors.forename: Frank
authors.initials: F
authors.lastname: Anderson
authors.forename: Gwyn
authors.initials: G
authors.lastname: Bebb
authors.forename: Nevin
authors.initials: N
authors.lastname: Murray
mesh_terms: D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008875:Middle Aged; D011799:Quinazolines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib